Image
Physician researchers have been receiving fellowships to study hematology and oncology at the NIH for more than 80 years, and it was one of the first training programs to be established. Our program’s alumni include accomplished and respected physicians conducting cutting-edge research at NIH and other premier research hospitals and institutions throughout the world.
Image
| program years | name of alumni | where they went after their fellowship |
|---|---|---|
| 2020-2023 | Sarah Atkins, M.D. | HealthPartners, Saint Paul, Minnesota Focus: Breast Oncology |
| 2022-2023 | Amrit Bhaskarla, D.O. | Hematologist and Oncologist, Northwestern Medical Group, Geneva, IL Focus: Community-based Heme/Onc Practice |
| 2020-2023 | Emily Bryer, D.O. | Assistant Professor, University of Pennsylvania Focus: Lymphoma |
| 2020-2023 | Rebecca Bystrom, M.D. | Advanced Fellowship in Leukemia, Dana Farber Cancer Institute Focus: Acute Leukemia, Medical Management |
| 2021-2023 | Stacey Doran, M.D. | Assistant Research Physician, NCI Center for Immuno-Oncology Focus: Adoptive Cell Therapy in Solid Tumors |
| 2020-2023 | Aamir Hussain, MBBS | Hematology Oncology Associates, Boca Raton, FL Focus: Community-based Heme/Onc Practice |
| 2020-2023 | Princess Mark-Adjeli, M.D. | Clinical Associate Professor, Johns Hopkins School of Medicine at Sibley Memorial Hospital Focus: Breast Oncology |
| 2020-2023 | Clay Reed, M.D. | Mercy Clinic Hematology and Oncology, Oklahoma City, OK Focus: Rural, Community-based Heme/Onc Practice |
| 2020-2023 | Krithika Shanmugasundaram, M.D. | Assistant Professor, Lymphoma and Cellular Therapy, University of Virginia Focus: CAR-T and Lymphoma |
Image
| PROGRAM YEARS | NAME OF ALUMNI | where they went after their fellowship |
|---|---|---|
| 2020-2022 | Pedro Alcedo Andrade, M.D. | Assistant Professor, Department of Medicine, Division of Hematology and Oncology, Georgetown University School of Medicine, MedStar Georgetown University Hospital Focus: Classical Hematology |
| 2020-2023 | Mohammad Atiq, M.D. | Assistant Professor, Genitourinary Malignancies Program, Section of Hematology/Oncology, University of Chicago Focus: Genitourinary Malignancies |
| 2018-2022 | Christopher Cole, M.D., Ph.D. | Medical Director, Palleon Pharmaceuticals |
| 2019-2022 | Parth Desai, MBBS | Clinical investigator, Department of Medical Oncology, Fox Chase Cancer Center at Temple University Hospital Focus: Head & Neck and Lung Cancers |
| 2019-2022 | Nina Kim, M.D. | Physician at the U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER), Division of Hematologic Malignancies I (DHMI) Focus: Hematologic Malignancies |
| 2020-2022 | Rialnat Lawal, MD., Ph.D. | Advanced Research Fellow – Translational and Functional Genomics Branch, mentor: Paul Liu Focus: Sickle Cell Disease |
| 2019-2022 | Meredith Jo McAdams, M.D. | Assistant Research Physician, NCI Thoracic and Gastrointestinal Malignancies Branch Focus: Thymic Cancer |
| 2020-2022 | John Molina, M.D., M.Ed. | Associate Staff Clinician, Cleveland Clinic Focus: AYA Hematologic Malignancies |
| 2020-2022 | Thomas A. Odeny, M.D., M.P.H., Ph.D. | Assistant Professor, Department of Medicine Oncology Division, Washington University School of Medicine, St. Louis, MO Focus: Global Oncology |
| 2019-2022 | Yifan Pang, M.D. | Attending Physician, Atrium Health Levine Cancer Institute Department of Hematologic Oncology and Blood Disorders Focus: Allogeneic Hematopoietic Cell Transplantation |
| 2019-2022 | Kamil Rechache, M.D. | Assistant Research Physician, Center for Immuno-Oncology, NCI, NIH; Associate Program Director, NIH Hematology Oncology Fellowship Focus: Allogeneic Hematopoietic Cell Transplantation |
| 2020-2022 | Nicholas Simon, M.D. | Assistant Research Physician, Genitourinary Malignancies Branch, NCI, NIH Focus: Bladder Cancer |
| 2019-2022 | Joseph Wooley, M.D. | Associate Staff Clinician, Cleveland Clinic Focus: Sarcoma, Phase 1 studies |
Image
| program years | name of alumni | where they went after their fellowship |
|---|---|---|
| 2018-2021 | Kathryn Cappell, M.D., Ph.D. | Hematologist/Oncologist specializing in hematologic malignancies, Inova Schar Cancer Institute, Fairfax, Virginia |
| 2018-2021 | Vincent Chau, M.D., Ph.D. | Medical Monitor, Loxo Oncology |
| 2019-2021 | Sarah Jenkins, M.D., Ph.D. | Hematologist and Oncologist, University of Tennessee Medical Center |
| 2018-2021 | Yazan Migdady, M.D. | Assistant Professor, Oregon Health & Science University (OHSU) Knight Cancer Institute Division of Hematology & Medical Oncology |
| 2019-2021 | Danielle Pastor, D.O., Ph.D. | Assistant Research Physician, NCI Laboratory of Tumor Immunology and Biology’s Clinical Trials Group |
| 2018-2021 | Guillaume Pegna, M.D. | Assistant Professor, Oregon Health & Science University (OHSU) Knight Cancer Institute Division of Hematology & Medical Oncology |
| 2019-2021 | Jeevan Puthiamadathil, M.D. | Medical Officer, U.S. Food and Drug Administration Center for Drug Evaluation and Research Office of Oncologic Diseases |
| 2018-2021 | Mohamed Samour, M.D. | Associate Physician, Geisinger |
| 2018-2021 | Nebojša Skorupan, M.D. | Assistant Research Physician, NCI Laboratory of Molecular Biology |
Image
| Program Years | Name of Alumni | where they went after their fellowship |
|---|---|---|
| 2017-2020 | Kyunghee Burkitt, D.O., Ph.D. | Assistant Professor, Case Western Reserve University School of Medicine |
| 2018-2020 | Dai Chihara, M.D., Ph.D. | Assistant Professor, MD Anderson Cancer Center, Department of Lymphoma/Myeloma |
| 2017-2020 | Joseph Clara, M.D. | Assistant Research Physician, NHLBI Cellular and Molecular Therapeutics Branch |
| 2018-2020 | Zishuo Ian Hu, M.D., Ph.D. | Assistant Professor, MD Anderson Cancer Center, Department of GI Medical Oncology |
| 2017-2020 | Peter DeMaria, M.D. | Medical Officer, FDA Center for Drug Evaluation and Research Office of Oncologic Diseases Division of Hematologic Malignancies |
| 2018-2020 | Shruti Gandhy, M.D., Ph.D. | Medical Officer, FDA Oncology Center of Excellence |
| 2017-2020 | Sabrina Khan, M.D. | Study Physician and Cancer and Research Scholar, AstraZeneca |
| 2017-2020 | Elizabeth Hill, M.D. | Assistant Research Physician, NCI Lymphoid Malignancies Branch (formerly FDA/NCI joint position) |
| 2017-2020 | Andy Itsara, M.D. | Assistant Research Physician, NHLBI |
| 2017-2020 | Rahul Lakhotia, M.D. | Assistant Research Physician, NCI Lymphoid Malignancies Branch |
| 2017-2020 | Paul Leger, M.D. | Assistant Professor, Genitourinary Malignancies, MedStar Georgetown University Hospital |
| 2017-2020 | Maria Pia Morelli, M.D., Ph.D. | Assistant Professor, MD Anderson Cancer Center, Department of GI Medical Oncology |
| 2018-2020 | Sujay Shah, M.D. | Medical Director, Janssen |
| 2018-2020 | Nobuyuki Takahashi, M.D., Ph.D. | Staff Clinician, Medical Oncology Service, National Center for Global Health and Medicine, Tokyo, Japan |
| 2018-2020 | Julia Z. Xu, M.D., M.Sc.G.H. | Assistant Professor of Medicine, Division of Hematology/Oncology, Vascular Medicine Institute, University of Pittsburgh Medical Center (formerly Assistant Research Physician, NHLBI) |
| Program Years | Name of Alumni | where they went after their fellowship |
|---|---|---|
| 2016-2019 | Munjid Al Harthy, M.D. | Staff Clinician, Sultan Qaboos Comprehensive Cancer Care and Research Center (formerly Assistant Research Physician, NCI) |
| 2018-2019 | Jennifer Carter, M.B.B.S. | Hematologist and Oncologist, Northwest Alabama Cancer Center, Muscle Shoals, AL |
| 2016-2019 | Gang Chen, M.D., Ph.D. | Community Practice, Silver Spring, MD |
| 2016-2019 | Julie Collins, M.D., M.P.H. | Global Medical Director, AstraZeneca |
| 2017-2019 | Charalampos Floudas, M.D., D.M.Sc., M.S. | Assistant Research Physician, NCI Genitourinary Malignancies Branch, with focus on head and neck cancers |
| 2017-2019 | Frank Lin, M.D. | Investigator, Molecular Imaging Program, NIH Lasker Clinical Research Scholar |
| 2016-2019 | Idrees Mian, M.D. | Hematologist and Oncologist, Kaiser Permanente, Largo, MD |
| 2016-2019 | Lekha Mikkilineni, M.D. | Assistant Research Physician, NCI Surgery Branch, with a focus is on developing and carrying out phase 1 clinical trials for CAR T-cell therapy targeting hematological malignancies |
| 2017-2019 | Cecilia Monge Bonilla, M.D., M.P.H. | Assistant Research Physician, NCI Thoracic and Gastrointestinal Malignancies Branch |
| 2016-2019 | Christopher Pleyer, M.D. | Assistant Research Physician, NHLBI (and Associate Director, NIH Hematology Oncology Fellowship) |
| 2016-2019 | Changqing Xie, M.D., Ph.D. | Physician Scientist Early Investigator, NCI Thoracic and GI Malignancies Branch (formerly Assistant Clinical Investigator with same branch) |
| 2016-2019 | Chen Zhao, M.D. | Physician-Scientist Early Investigator, NCI Thoracic and GI Malignancies Branch (formerly Investigator Assistant Clinical Investigator for the same branch) |
| Program Years | Name of Alumni | where they went after their fellowship |
|---|---|---|
| 2015-2018 | Daisuke Araki, M.D. | Assistant Research Physician, NHLBI |
| 2015-2018 | Tara Berman, M.D. | Medical Oncologist, Inova (formerly Medical Officer, U.S. Food and Drug Administration) |
| 2017-2018 | Amine Achhal El Kadmiri, M.D. | Community Practice, affiliated with Metro Nashville General Hospital |
| 2016-2018 | Azam Ghafoor, M.D. | Assistant Research Physician, NCI Thoracic and GI Malignancies Branch |
| 2015-2018 | Vid Leko, M.D. | Physician-Scientist Early Investigator, NCI (formerly Postdoctoral Fellow, NCI with Stephen Rosenberg, M.D., Ph.D.) |
| 2015-2018 | Kathryn Lurain, M.D., M.P.H. | Assistant Research Physician, NCI HIV and AIDS Malignancy Branch and Associate Program Director, NIH Hematology Oncology Fellowship |
| 2015-2018 | Rosa Nadal Rios, M.D. | Assistant Research Physician, NHLBI |
| 2016-2018 | Scott Norberg, D.O. | Assistant Research Physician, NCI Experimental Transplantation and Immunology Branch |
| 2015-2018 | Karolyn Oetjen, M.D., Ph.D. | Instructor, Stem Cell Biology, Washington University School of Medicine, St. Louis MO |
| 2016-2018 | Jason Redman, M.D. | Assistant Research Physician, NCI Genitourinary Malignancies Branch |
| Program Years | Name of Alumni | where they went after their fellowship |
|---|---|---|
| 2014-2017 | Stefan Cordes, M.D., Ph.D. | Assistant Research Physician, NHLBI |
| 2015-2017 | Jaydira Del Rivero, M.D. | Assistant Research Physician, NCI Pediatric Oncology Branch, developing the Rare Tumor Natural History study and Rare Tumor Clinic |
| 2014-2017 | Farhad Fakherjahani, M.D. | Community Practice, Kaiser Permanente and Holy Cross Hospital |
| 2014-2017 | Eitan Friedman, M.D. | Community Practice, affiliated wiht United Oncology Medical Associates of Florida LLC and Jackson North Medical Center |
| 2015-2017 | Margaret Gatti-Mays, M.D. | Assistant Professor, The Ohio State University Comprehensive Cancer Center Division of Medical Oncology |
| 2014-2017 | Kazusa Ishii, M.D., M.P.H. | Assistant Research Physician, NCI Experimental Transplantation and Immunology Branch |
| 2014-2017 | Chul Kim, M.D., M.P.H. | Assistant Professor, MedStar Georgetown University Hospital |
| 2015-2017 | Hoyoung Maeng, M.D. | Assistant Research Physician, NCI Vaccine Branch |
| 2014-2017 | Christopher Melani, M.D. | Assistant Research Physician, NCI Lymphoid Malignancies Branch, specializing in lymphoma |
| 2014-2017 | Milos Miljković, M.D., M.Sc. | Chief Medical Officer, Cartesian Therapeutics |
| 2015-2017 | Ana Nunes, M.D., Ph.D. | Study Physician, AstraZeneca |
| 2013-2017 | Georgios Pongas, M.D. | Assistant Professor, University of Miami, specializing in lymphoma and CLL |
| 2015-2017 | Nitin Roper, M.D., M.Sc. | Assistant Clinical Investigator, NCI Developmental Therapeutics Branch, research focus on high-grade neuroendocrine tumors, including small cell lung cancers, bladder, prostate, pancreatic and non-small cell cancers that transform to high-grade neuroendocrine cancers |
| 2014-2017 | Sanaz Soltani, M.D. | Assistant Professor, Department of Medicine, West Virginia University Cancer Institute |
| 2014-2017 | Phuong Vo, M.D. | Assistant Professor, Fred Hutchinson Cancer Research Center and University of Washington Division of Medical Oncology |
| Program Years | Name of Alumni | where they went after their fellowship |
|---|---|---|
| 2013-2016 | Inhye Ahn, M.D. | Faculty, Dana-Farber Cancer Institute (formerly Assistant Research Physician, NHLBI) |
| 2013-2016 | Jennifer Brudno, M.D. | Associate Research Physician, NCI, researches the use of chimeric antigen receptor (CAR) T-cell therapy to treat cancers of the blood, including Non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphoblastic leukemia (ALL), and multiple myeloma |
| 2013-2016 | Haobin Chen, M.D., Ph.D. | Assistant Clinical Investigator, NCI, researches novel therapies for small cell lung cancer |
| 2012-2016 | James Cooper, M.D. | Medical Director, Genentech |
| 2013-2016 | Oxana (Rusher) Crysler, M.D. | Clinical Assistant Professor, University of Michigan Medical School |
| 2014-2016 | Nicole Davarpanah, M.D. | Assistant Medical Director, Product Development Oncology, Genentech , Inc. |
| 2010-2016* | Bogdan Dumitriu, M.D. | Community Practice, Kaiser Permanente, Largo, MD |
| 2014-2016 | Jennifer Gao, M.D. | Medical Oncologist, Food and Drug Administration Division of Oncology Products 1 Breast Cancer team |
| 2015-2016 | Monalisa Ghosh, M.D. | Assistant Professor, University of Michigan Medical School |
| 2014-2016 | Daniel Lee, M.D., Ph.D. | Assistant Professor, University of Pittsburgh Medical Center, with interest in genitourinary tumors |
| 2012-2016 | Sandya Panch, M.D., M.P.H. | Associate Professor, University of Washington Division of Hematology; Director of Transfusion Fred Hutchinson Cancer Center (formerly Medical Director, Center for Cellular Engineering, NIH Department of Transfusion Medicine) |
| 2013-2016 | Julius Strauss, M.D. | Associate Research Physician, NCI Laboratory of Tumor Immunology and Biology (LTIB) and Co-Director of the LTIB's Clinical Trials Group |
| 2013-2016 | Clare Sun, M.D. | Assistant Research Physician, NHLBI |
| Program Years | Name of Alumni | where they went after their fellowship |
|---|---|---|
| 2012-2015 | Syed Abbas Ali, M.B.B.S. | Assistant Professor, Johns Hopkins Medicine Kimmel Cancer Center |
| 2013-2015 | Victoria Chiou, M.D. | Global Medical Director, Cell & Gene Therapy, GSK |
| 2013-2015 | Neil Dunavin, M.D. | Clinical Hematologist, University of California at San Francisco |
| 2013-2015 | Priscilia Gonçalves, M.D. | Medical Director, Regeron Pharmaceuticals, Inc. |
| 2012-2015 | Moonjung Jung, M.D. | Clinical Scholar and Instructor in Clinical Investigation, Rockefeller University |
| 2012-2015 | David Kotlyar, M.D. | Community Practice, Bethesda and Hagerstown, MD |
| 2013-2015 | Metin Kurtoglu, M.D., Ph.D. | Chief Operating Officer, Cartesian Therapeutics |
| 2012-2015 | Sham Mailankody, M.B.B.S. | Medical Oncologist specializing in plasma cell disorders at Memorial Sloan Kettering Cancer Center |
| 2012-2015 | Ciara O'Sullivan, M.B., B.Ch. | Associate Professor of Oncology, Mayo Clinic Cancer Center |
| 2012-2015 | Geraldine O'Sullivan Coyne, M.D., Ph.D. | Assistant Research Physician, NCI Early Clinical Trials Development Program |
| 2012-2015 | Vinayak Prasad, M.D., M.P.H. | Associate Professor of Medicine, University of California San Francisco Department of Epidemiology and Biostatistics; runs the VK Prasad Laboratory at UCSF |
| 2012-2015 | Enkhee Purev, M.D., Ph.D. | Associate Medical Director, Product Development, Genentech |
| 2012-2015 | Harpreet "Bonnie" Singh, M.D. | Acting Director, Division of Oncology 2, U.S. Food and Drug Administration, focus on thoracic, head & neck cancers, neuro-oncology, rare cancers, pediatric solid tumors |
| 2012-2015 | Ira Surolia, M.D. | Medical Hematologist and Oncologist, Columbia University Irving Medical Center |
| 2012-2015 | Alexandra Zimmer, M.D. | Associate Professor and Breast Cancer Program Director, Oregon Health & Science University (OHSU) Hematology & Oncology Division (formerly Assistant Research Physician, NCI Women's Malignancies Branch) |
| Program Years | Name of Alumni | where they went after their fellowship |
|---|---|---|
| 2011-2014 | Christina Alewine, M.D., Ph.D. | NCI Lasker Scholar, Laboratory of Molecular Cancer, with a focus on use of immunotoxin therapies in pancreatic cancer |
| 2011-2014 | Manisha Bhutani, M.D. | Hematology, Atrium Health Levine Cancer Institute |
| 2011-2014 | Mauricio Burotto Pichun, M.D. | Medical Director, Bradford Hill Clinical Research; Medical Oncologist, Clínica Universidad de los Andes, Chile |
| 2012-2014 | Yuanbin Chen, M.D., Ph.D. | Medical Oncologist, Cancer & Hematology Centers of Western Michigan |
| 2011-2014 | Lauren Curtis, M.D. | Assistant Professor of Oncology, Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital |
| 2011-2014 | Jan Davidson-Moncada, M.D., Ph.D. | Senior Director, Clinical Research at MacroGenics Inc. |
| 2011-2014 | Helen Gharwan, M.D., Ph.D. | Internal Medicine, Northern Light Health |
| 2010-2014 | Christian Hinrichs, M.D. | Chief of the Section of Cancer Immunotherapy and Co-Director of the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence, Rutgers Cancer Institute of New Jersey (formerly NIH Lasker Clinical Research Scholar, Experimental Transplantation and Immunotherapy Branch) |
| 2011-2014 | Catherine Lai, M.D., M.P.H. | Associate Professor of Clinical Medicine, Penn Medicine (formerly Director of Leukemia at MedStar Georgetown University Hospital’s Lombardi Comprehensive Cancer Center |
| 2011-2014 | Kit Lu, M.D. | Medical Hematologist and Oncologist, UPMC Pinnacle, Harrisburg, PA |
| 2011-2014 | Sabrina Martyr, M.D. | Medical Hematologist and Oncologist, WellSpan Medical Group, Haover, PA |
| 2011-2014 | Avani Shah, M.D. | Medical Director, Novartis Pharmaceuticals, Breast Oncology Division |
| 2011-2014 | Nishant Tageja, M.D. | Medical Oncologist and Hematologist, UPMC Hillman Cancer Center |
| 2011-2014 | Susanna Ulahannan, MD, MMed | Assistant Professor of Hematology and Oncology, Oklahoma University Medicine; Associate Director of the Oklahoma TSET Phase I Program |